Agilent launches new AriaDx real-time PCR system in Europe

Agilent Technologies has announced the European launch of AriaDx, a new modular solution for clinical diagnostic labs and assay developers.

The real-time polymerase chain reaction (PCR) system is designed to help identify pathogens, genotype infectious agents, and for cancer diagnostics. AriaDx is the only modular real-time PCR instrument on the market intended for in vitro diagnostic use.

Its modular design incorporates changeable optics, allowing labs to set up AriaDx with a single optical cartridge and add up to six in total as required. The system also provides intuitive touchscreen controls and analysis software to further increase its user-friendliness and versatility.

AriaDx is ideally suited for assays detecting gene expression, allele discrimination and genotyping, as well as being compatible with existing fast chemistry-based assays that are DNA-binding and probe-based.

Jeff Heimburger, head of genomics marketing at Agilent, said: "We are excited to provide a new generation of flexible qPCR diagnostics instrumentation for our partners creating molecular diagnostic assays."

The device has received European CE Mark approval and is now ready for launch in Europe.

With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.